News & Perspective

May 10, 2013

May 10, 2013

Experts offer dim view of potential vaccine response to H7N9

If the H7N9 influenza virus now circulating in China evolves into a pandemic strain, the world is likely to have great difficulty providing adequate supplies of an effective vaccine in time to blunt its impact, according to a viewpoint article by three experts in the Journal of the American Medical Association (JAMA).

Feb 10, 2009

Feb 10, 2009

Panasonic's pandemic-related move fuels questions, concern

(CIDRAP News) – News reports that Panasonic Corp. has asked some of its overseas employees to send their families home to Japan because of the threat of pandemic influenza fueled puzzlement and speculation today about the global H5N1 risk and whether other companies might follow suit.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Feb 06, 2007

Feb 06, 2007

2007 SUMMIT COVERAGE: CDC chief calls pandemic preparedness a marathon

(CIDRAP News) – Orlando, FL – Julie Gerberding, MD, director of the Centers for Disease Control and Prevention (CDC), today challenged health and business leaders to stay focused on the "marathon" of preparing for an influenza pandemic.

Gerberding, speaking at a conference on business preparedness, said it's not possible to maintain high public interest in the pandemic threat indefinitely, but leaders must keep preparing anyway.

Nov 03, 2006

Nov 03, 2006

Study says new H5N1 strain pervades southern China

(CIDRAP News) – A new subtype of H5N1 avian influenza virus has become predominant in southern China over the past year, possibly through its resistance to vaccines used in poultry, and has been found in human H5N1 cases in China, according to researchers from Hong Kong and the United States.

Nov 02, 2006

Nov 02, 2006

WHO report calls H5N1 vaccine stockpiling premature

(CIDRAP News) – A group of influenza experts convened by the World Health Organization cautioned today that governments shouldn't stockpile "pre-pandemic" H5N1 influenza vaccines now, because too little is known about the requirements for an effective vaccine.

Aug 18, 2006

Aug 18, 2006

WHO changes H5N1 strains for pandemic vaccines, raising concern over virus evolution

(CIDRAP News) – The World Health Organization (WHO) today changed the H5N1 avian influenza strains recommended for candidate vaccines for the first time since 2004, causing some experts to question how far the virus has evolved.

The WHO's new prototype strains, prepared by reverse genetics, include three new H5N1 subclades.

Jan 05, 2006

Jan 05, 2006

YEAR-END REVIEW: Avian flu emerged as high-profile issue in 2005

Jan 6, 2006 (CIDRAP News) – 2005 is likely to go down as the year when avian influenza, powered by a steady rise in human cases and the spread of poultry outbreaks all the way to Eastern Europe, emerged as a high-profile global health issue.

When 2005 dawned, only 45 human cases of H5N1 avian flu, including 32 deaths, had been counted by the World Health Organization (WHO). All of those were in Vietnam and Thailand.

Jun 20, 2005

Jun 20, 2005

China's alleged use of human flu drug in poultry questioned

(CIDRAP News) – International health agencies are questioning China about a report that the country has used a human antiviral drug in poultry for years, thereby causing the H5N1 influenza virus to become resistant to the drug.

May 26, 2005

May 26, 2005

Nature urges world to take pandemic threat seriously

(CIDRAP News) – The British magazine Nature trained a floodlight on the threat of an influenza pandemic today with a collection of 10 articles that explore the danger and possible remedies and demand a more serious global response.

"The level of current efforts is not commensurate with the threat we face," the editors write. "The time for diplomacy and denial is over. It is time for advocacy and action."

Sort Results By:

 Sort Results By:

Narrow results by:

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»